Itacitinib prevents xenogeneic GVHD in humanized mice-Reference-Cited by-同舟云学术

Itacitinib prevents xenogeneic GVHD in humanized mice

Published:2021-06-25 Issue:11 Volume:56 Page:2672-2681
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Courtois Justine,Ritacco Caroline,Dubois Sophie,Canti Lorenzo,Vandenhove Benoît,Seidel Laurence^ORCID,Daulne Coline,Caers Jo,Servais Sophie,Beguin Yves,Ehx Grégory,Baron Frédéric^ORCID

Funder

Fonds De La Recherche Scientifique - FNRS

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-021-01363-1.pdf

Reference35 articles.

1. Baron F, Efficace F, Cannella L, Muus P, Trisolini S, Halkes CJM, et al. Impact of the type of anthracycline and of stem cell transplantation in younger patients with acute myeloid leukemia: Long-term follow up of a phase III study. Am J Hematol. 2020;95:749–58.

2. Baron F, Maris MB, Sandmaier BM, Storer BE, Sorror M, Diaconescu R, et al. Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. J Clin Oncol. 2005;23:1993–2003.

3. Hammarén HM, Virtanen AT, Raivola J, Silvennoinen O. The regulation of JAKs in cytokine signaling and its breakdown in disease. Cytokine. 2019;118:48–63.

4. Schroeder MA, Choi J, Staser K, DiPersio JF. The role of janus kinase signaling in graft-versus-host disease and graft versus leukemia. Biol Blood Marrow Transpl. 2018;24:1125–34.

5. Zeiser R, von Bubnoff N, Butler J, Mohty M, Niederwieser D, Or R, et al. Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease. N. Engl J Med. 2020;382:1800–10.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of human AML cells to study graft-versus-leukemia immunity in xenogeneic mouse models of GVHD;2024-05-02

2. The Effects of Busulfan on Xenogeneic Transplantation of Human Peripheral Blood Mononuclear Cells in Recipient Mice;Transplantation Proceedings;2024-03

3. Janus kinase inhibition in the treatment and prevention of graft-versus-host disease;Frontiers in Immunology;2024-02-06

4. Graft‐versus‐leukaemia immunity is retained following treatment with post‐transplant cyclophosphamide alone or combined with tocilizumab in humanised mice;Clinical & Translational Immunology;2024-01

5. Oral small molecule agents in management of ulcerative colitis: fact or fancy;Turkish Journal of Medical Sciences;2023-12-12